NCT07519434

Brief Summary

This study aims to develop and validate a deep learning-based electrocardiogram (ECG) model for predicting the future risk of heart failure with reduced ejection fraction (HFrEF). The model is trained using raw 12-lead ECG data and generates individualized, time-resolved risk estimates over a 5-year period. Data are obtained from multiple cohorts, including Zhongshan Hospital, Shanghai Tenth People's Hospital, and Beth Israel Deaconess Medical Center, representing diverse populations across China and the United States. The model is designed to identify individuals at elevated risk of developing HFrEF before the onset of overt clinical disease. The performance of the model is evaluated using multiple complementary metrics, including discrimination, calibration, and clinical utility. In addition, interpretability analyses are conducted to explore the physiological relevance of ECG features associated with predicted risk. This study seeks to provide an accessible and scalable tool for early risk stratification of heart failure, with the potential to support timely clinical decision-making and improve patient outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
286,709

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
9.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

April 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 9, 2026

Completed
Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

9.8 years

First QC Date

April 2, 2026

Last Update Submit

April 2, 2026

Conditions

Keywords

ElectrocardiogramArtificial IntelligenceDeep LearningSurvival ModelTime-to-Event PredictionRisk StratificationHeart Failure PredictionECG-based Prediction

Outcome Measures

Primary Outcomes (1)

  • Incident Heart Failure With Reduced Ejection Fraction (HFrEF)

    Occurrence of heart failure with reduced ejection fraction (HFrEF), defined as a left ventricular ejection fraction (LVEF) ≤40% during follow-up, as determined by transthoracic echocardiography. Both prevalent and incident cases identified from ECG-echocardiography data are included.

    Up to 5 years

Study Arms (1)

Overall Study Population

Participants from three independent cohorts (Zhongshan Hospital, Shanghai Tenth People's Hospital, and Beth Israel Deaconess Medical Center) who underwent standard 12-lead electrocardiography and echocardiographic evaluation. These data were used to develop and externally validate a deep learning model for time-to-event prediction of incident heart failure with reduced ejection fraction (HFrEF). No interventions were assigned, as this was an observational study based on routinely collected clinical data.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants were derived from three independent cohorts, including Zhongshan Hospital, Shanghai Tenth People's Hospital, and Beth Israel Deaconess Medical Center. The study population included adult patients who underwent routine ECG and echocardiographic evaluation in real-world clinical settings.

You may qualify if:

  • Adults aged ≥18 years Underwent standard 12-lead electrocardiography (ECG) Underwent transthoracic echocardiography with available LVEF measurement Availability of paired ECG-echocardiography data Data available for follow-up assessment

You may not qualify if:

  • Missing or incomplete ECG or echocardiography data Poor-quality ECG recordings unsuitable for analysis Missing key clinical variables required for model development

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Shanghai, Shanghai Municipality, 200436, China

Location

MeSH Terms

Conditions

Heart FailureVentricular Dysfunction, Left

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVentricular Dysfunction

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 9, 2026

Study Start

February 1, 2014

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

This study uses retrospective clinical data that are not publicly shareable.

Locations